Impact of symptomatic multiple sclerosis therapy on pregnancy outcome

Information on symptomatic therapy (ST) use in women of childbearing age with multiple sclerosis is sparse, and data on the impact of ST pregnancy exposure on pregnancy outcome are lacking.